UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

The trouble with radicalization

International affairs (London), 2013-07, Vol.89 (4), p.873-893

NEUMANN, PETER R.

2013

Link zum Volltext

Verfügbarkeit prüfen

Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

The New England journal of medicine, 2014-08, Vol.371 (9), p.796-797

2014

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine

JAMA : the journal of the American Medical Association, 2016-09, Vol.316 (10), p.1093

2016

Link zum Volltext

Verfügbarkeit prüfen

Measuring the Value of Prescription Drugs

The New England journal of medicine, 2015-12, Vol.373 (27), p.2595-2597

2015

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness Analysis 2.0

The New England journal of medicine, 2017-01, Vol.376 (3), p.203-205

2017

Link zum Volltext

Verfügbarkeit prüfen

Compact solar autoclave based on steam generation using broadband light-harvesting nanoparticles

Proceedings of the National Academy of Sciences - PNAS, 2013-07, Vol.110 (29), p.11677-11681

2013

Link zum Volltext

Verfügbarkeit prüfen

Colloidal suspensions of clay or titanium dioxide nanoparticles can inhibit leaf growth and transpiration via physical effects on root water transport

Plant, cell and environment, 2009-05, Vol.32 (5), p.577-584

2009

Link zum Volltext

Verfügbarkeit prüfen

Yes, Improve the US Value Frameworks, But Recognize They Are Already in Prime Time

Value in health, 2019-09, Vol.22 (9), p.975-976

Neumann, Peter J., ScD

2019

Link zum Volltext

Verfügbarkeit prüfen

Turning CMS into a Health Technology Assessment Organization

The New England journal of medicine, 2023-08, Vol.389 (8), p.682-684

2023

Link zum Volltext

Verfügbarkeit prüfen

Legislating against Use of Cost-Effectiveness Information

The New England journal of medicine, 2010-10, Vol.363 (16), p.1495-1497

2010

Link zum Volltext

Verfügbarkeit prüfen

Prevention of non-communicable disease: best buys, wasted buys, and contestable buys

BMJ (Online), 2020-01, Vol.368, p.m141

2020

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness Studies in the ICU: A Systematic Review

Critical care medicine, 2019-08, Vol.47 (8), p.1011

2019

Link zum Volltext

Verfügbarkeit prüfen

Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy

Value in health, 2019-06, Vol.22 (6), p.661-668

2019

Link zum Volltext

Verfügbarkeit prüfen

A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7]

Value in health, 2018-02, Vol.21 (2), p.161-165

2018

Link zum Volltext

Verfügbarkeit prüfen

Medicare and Medical Technology — The Growing Demand for Relevant Outcomes

The New England journal of medicine, 2010-02, Vol.362 (5), p.377-379

2010

Link zum Volltext

Verfügbarkeit prüfen

Toward Better Data Dashboards for US Drug Value Assessments

Value in health, 2021-10, Vol.24 (10), p.1484-1489

Neumann, Peter J.

2021

Link zum Volltext

Verfügbarkeit prüfen

A Call for Open-Source Cost-Effectiveness Analysis

Annals of internal medicine, 2017-09, Vol.167 (6), p.432

2017

Link zum Volltext

Verfügbarkeit prüfen

Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis

Journal of the American Geriatrics Society (JAGS), 2016-08, Vol.64 (8), p.1549-1557

2016

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness Thresholds Used by Study Authors, 1990-2021

JAMA : the journal of the American Medical Association, 2023-04, Vol.329 (15), p.1312

2023

Link zum Volltext

Verfügbarkeit prüfen

Future Directions for Cost-effectiveness Analyses in Health and Medicine

Medical decision making, 2018-10, Vol.38 (7), p.767-777

2018

Link zum Volltext

Verfügbarkeit prüfen

Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions

PharmacoEconomics, 2019-04, Vol.37 (4), p.597-608

2019

Link zum Volltext

Verfügbarkeit prüfen

Health technology assessment for gene therapies in haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-03, Vol.28 (S2), p.19-26

2022

Link zum Volltext

Verfügbarkeit prüfen

Does Preventive Care Save Money? Health Economics and the Presidential Candidates

The New England journal of medicine, 2008-02, Vol.358 (7), p.661-663

2008

Link zum Volltext

Verfügbarkeit prüfen

Drug-Pricing Debate Redux — Should Cost-Effectiveness Analysis Be Used Now to Price Pharmaceuticals?

The New England journal of medicine, 2021-11, Vol.385 (21), p.1923-1924

2021

Link zum Volltext

Verfügbarkeit prüfen

The History and Future of the “ISPOR Value Flower”: Addressing Limitations of Conventional Cost-Effectiveness Analysis

Value in health, 2022-04, Vol.25 (4), p.558-565

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 98.736

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74.886)
Mit Volltextzugriff
(92.323)

Publikationsform

10 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(92.438)
Japanisch
(8.895)
Deutsch
(8.468)
Französisch
(728)
Spanisch
(633)
Portugiesisch
(568)
Norwegisch
(118)
Italienisch
(78)
Ungarisch
(74)
Polnisch
(53)
Russisch
(53)
Tschechisch
(51)
Slowakisch
(41)
Türkisch
(39)
Ndonga
(38)
Bokmål, Norwegian; Norwegian Bokmål
(37)
Niederländisch
(30)
Slowenisch
(19)
Rumänisch
(17)
Croatian
(16)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(49.862)
Life Sciences & Biomedicine
(33.060)
Humans
(19.232)
Physical Sciences
(12.123)
Social Sciences
(9.489)
Technology
(8.756)
Animals
(8.583)
Male
(8.403)
Female
(8.277)
Biological And Medical Sciences
(5.936)
Chemistry
(4.972)
Middle Aged
(4.430)
Biochemistry & Molecular Biology
(4.209)
Adult
(4.129)
Neurosciences & Neurology
(4.013)
Medical Sciences
(4.003)
Physics
(3.661)
Neurosciences
(3.660)
Computer Science
(3.586)
Aged
(3.475)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(38.344)
Electronic Journals Library
(29.674)
Elsevier ScienceDirect Journals Complete
(16.315)
IngentaConnect Journals
(15.984)
Journals@Ovid Complete
(14.912)
Wiley Online Library
(12.616)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(12.046)
SpringerNature Journals
(10.847)
Ebook Central Perpetual and DDA
(9.660)
Jstor Complete Legacy
(9.565)
Wiley Online Library Full Collection 2018
(9.550)
eBooks on EBSCOhost
(9.434)
NUS Single-Journal Subscriptions
(8.548)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(7.088)
Business Source Ultimate
(4.650)
Taylor & Francis Current Content Access
(4.057)
Taylor & Francis:Master (3349 titles)
(4.026)
De Gruyter eBooks
(3.948)
Factiva
(3.181)
Worldwide Political Science Abstracts
(2.982)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(1.058)
The Hollywood Reporter
(832)
Angewandte Chemie
(784)
Communications Of The Acm
(445)
International Journal Of Molecular Sciences
(435)
The Journal Of Biological Chemistry
(380)
Scientific Reports
(339)
Chemistry : A European Journal
(256)
The American Journal Of Cardiology
(256)
Journal Of The American College Of Cardiology
(233)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The trouble with radicalization

Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine

Measuring the Value of Prescription Drugs

Cost-Effectiveness Analysis 2.0

Compact solar autoclave based on steam generation using broadband light-harvesting nanoparticles

Colloidal suspensions of clay or titanium dioxide nanoparticles can inhibit leaf growth and transpiration via physical effects on root water transport

Yes, Improve the US Value Frameworks, But Recognize They Are Already in Prime Time

Turning CMS into a Health Technology Assessment Organization

Legislating against Use of Cost-Effectiveness Information

Prevention of non-communicable disease: best buys, wasted buys, and contestable buys

Cost-Effectiveness Studies in the ICU: A Systematic Review

Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy

A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7]

Medicare and Medical Technology — The Growing Demand for Relevant Outcomes

Toward Better Data Dashboards for US Drug Value Assessments

A Call for Open-Source Cost-Effectiveness Analysis

Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis

Cost-effectiveness Thresholds Used by Study Authors, 1990-2021

Future Directions for Cost-effectiveness Analyses in Health and Medicine

Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions

Health technology assessment for gene therapies in haemophilia

Does Preventive Care Save Money? Health Economics and the Presidential Candidates

Drug-Pricing Debate Redux — Should Cost-Effectiveness Analysis Be Used Now to Price Pharmaceuticals?

The History and Future of the “ISPOR Value Flower”: Addressing Limitations of Conventional Cost-Effectiveness Analysis

Suchergebnisse filtern